Xuan Marian Thai

Array ( [id] => 4995106 [patent_doc_number] => 20070010451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-11 [patent_title] => 'Method of protecting cells against damage and pharmaceutical composition comprising leumorphin' [patent_app_type] => utility [patent_app_number] => 11/482480 [patent_app_country] => US [patent_app_date] => 2006-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 8555 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20070010451.pdf [firstpage_image] =>[orig_patent_app_number] => 11482480 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4994089 [patent_doc_number] => 20070009434 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-11 [patent_title] => 'Imaging and therapeutic method using monocytes' [patent_app_type] => utility [patent_app_number] => 11/481264 [patent_app_country] => US [patent_app_date] => 2006-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10883 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20070009434.pdf [firstpage_image] =>[orig_patent_app_number] => 11481264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5075284 [patent_doc_number] => 20070015259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-18 [patent_title] => 'Fusion partner for production of monoclonal rabbit antibodies' [patent_app_type] => utility [patent_app_number] => 11/476277 [patent_app_country] => US [patent_app_date] => 2006-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7218 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20070015259.pdf [firstpage_image] =>[orig_patent_app_number] => 11476277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4994257 [patent_doc_number] => 20070009602 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-11 [patent_title] => 'Direct drug delivery system based on thermally responsive biopolymers' [patent_app_type] => utility [patent_app_number] => 11/472113 [patent_app_country] => US [patent_app_date] => 2006-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7609 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20070009602.pdf [firstpage_image] =>[orig_patent_app_number] => 11472113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 82680 [patent_doc_number] => 07740856 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-22 [patent_title] => 'Effect of BST2 on inflammation' [patent_app_type] => utility [patent_app_number] => 11/471853 [patent_app_country] => US [patent_app_date] => 2006-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 32 [patent_no_of_words] => 20375 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/740/07740856.pdf [firstpage_image] =>[orig_patent_app_number] => 11471853 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5732848 [patent_doc_number] => 20060257965 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Extracellular matrix signalling molecules' [patent_app_type] => utility [patent_app_number] => 11/455506 [patent_app_country] => US [patent_app_date] => 2006-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 33166 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20060257965.pdf [firstpage_image] =>[orig_patent_app_number] => 11455506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 826987 [patent_doc_number] => 07402653 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-22 [patent_title] => 'Biologically active peptides' [patent_app_type] => utility [patent_app_number] => 11/455289 [patent_app_country] => US [patent_app_date] => 2006-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25542 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/402/07402653.pdf [firstpage_image] =>[orig_patent_app_number] => 11455289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4778292 [patent_doc_number] => 20080286290 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-20 [patent_title] => 'Anti-Cd14 Antibody Fusion Protein' [patent_app_type] => utility [patent_app_number] => 11/791888 [patent_app_country] => US [patent_app_date] => 2006-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 56 [patent_no_of_words] => 30970 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20080286290.pdf [firstpage_image] =>[orig_patent_app_number] => 11791888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5834221 [patent_doc_number] => 20060246051 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Polynucleotides encoding a novel testis-specific tubulin tyrosine-ligase-like protein, BGS42' [patent_app_type] => utility [patent_app_number] => 11/445988 [patent_app_country] => US [patent_app_date] => 2006-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 116820 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20060246051.pdf [firstpage_image] =>[orig_patent_app_number] => 11445988 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10887741 [patent_doc_number] => 08911733 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-16 [patent_title] => 'Inhibition of the alternative complement pathway for treatment of traumatic brain injury, spinal cord injury and related conditions' [patent_app_type] => utility [patent_app_number] => 11/441828 [patent_app_country] => US [patent_app_date] => 2006-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 25402 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11441828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 239712 [patent_doc_number] => 07592429 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-22 [patent_title] => 'Sclerostin-binding antibody' [patent_app_type] => utility [patent_app_number] => 11/411003 [patent_app_country] => US [patent_app_date] => 2006-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 50944 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/592/07592429.pdf [firstpage_image] =>[orig_patent_app_number] => 11411003 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5004539 [patent_doc_number] => 20070202107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'Novel kinases' [patent_app_type] => utility [patent_app_number] => 11/407888 [patent_app_country] => US [patent_app_date] => 2006-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 87 [patent_figures_cnt] => 87 [patent_no_of_words] => 101560 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20070202107.pdf [firstpage_image] =>[orig_patent_app_number] => 11407888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 152202 [patent_doc_number] => 07678891 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-16 [patent_title] => 'Antibodies that bind CCX-CKR2' [patent_app_type] => utility [patent_app_number] => 11/407729 [patent_app_country] => US [patent_app_date] => 2006-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15071 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/678/07678891.pdf [firstpage_image] =>[orig_patent_app_number] => 11407729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 849283 [patent_doc_number] => 07381802 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-03 [patent_title] => 'Human antibodies that specifically recognize the toxin Cn2 from Centruroides noxius scorpion venom' [patent_app_type] => utility [patent_app_number] => 11/404879 [patent_app_country] => US [patent_app_date] => 2006-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16304 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/381/07381802.pdf [firstpage_image] =>[orig_patent_app_number] => 11404879 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5677820 [patent_doc_number] => 20060183176 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Method and reagent for detecting cell death' [patent_app_type] => utility [patent_app_number] => 11/402538 [patent_app_country] => US [patent_app_date] => 2006-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4427 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20060183176.pdf [firstpage_image] =>[orig_patent_app_number] => 11402538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8796652 [patent_doc_number] => 08435519 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-07 [patent_title] => 'Antibodies that bind alpha subunit of sodium potassium ATPase' [patent_app_type] => utility [patent_app_number] => 11/910943 [patent_app_country] => US [patent_app_date] => 2006-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 39 [patent_no_of_words] => 19636 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11910943 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5850519 [patent_doc_number] => 20060233710 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Prevention and treatment for GVHD' [patent_app_type] => utility [patent_app_number] => 11/393283 [patent_app_country] => US [patent_app_date] => 2006-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7865 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20060233710.pdf [firstpage_image] =>[orig_patent_app_number] => 11393283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5596211 [patent_doc_number] => 20060160128 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Novel adenosine deaminase homolog' [patent_app_type] => utility [patent_app_number] => 11/386902 [patent_app_country] => US [patent_app_date] => 2006-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12958 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20060160128.pdf [firstpage_image] =>[orig_patent_app_number] => 11386902 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5705194 [patent_doc_number] => 20060194242 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Immunotherapy for immune suppressed patients' [patent_app_type] => utility [patent_app_number] => 11/374783 [patent_app_country] => US [patent_app_date] => 2006-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 21577 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20060194242.pdf [firstpage_image] =>[orig_patent_app_number] => 11374783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 252813 [patent_doc_number] => 07579447 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-25 [patent_title] => 'Antibodies against LLG polypeptides of the triacylglycerol lipase family' [patent_app_type] => utility [patent_app_number] => 11/369410 [patent_app_country] => US [patent_app_date] => 2006-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 18527 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/579/07579447.pdf [firstpage_image] =>[orig_patent_app_number] => 11369410 [rel_patent_id] =>[rel_patent_doc_number] =>)